Share Twitter LinkedIn Facebook Email Joan Schiller, MD, talks about the Keynote trials presented and whether they will impact her choice of therapy for squamous or non-squamous lung cancer patients at the Annual Meeting 2018 Annual Meeting.
VIDEO: iTeos and GSK’s TIGIT Combination Therapy Shows Significant Promise at ESMO 2024 Non-Small Cell Lung Cancer 2 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read